BJCM
Blue Jay Capital Management Portfolio holdings
AUM
$147M
1-Year Return
64.18%
This Quarter Return
+17.5%
1 Year Return
+64.18%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$224M
AUM Growth
–
Cap. Flow
+$224M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
51.23%
Holding
23
New
23
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Perrigo
PRGO
|
+$12.5M |
| 2 |
Smith & Nephew
SNN
|
+$12.5M |
| 3 |
RCPT
RECEPTOS INC COM STK (DE)
RCPT
|
+$12.3M |
| 4 |
Cooper Companies
COO
|
+$12.2M |
| 5 |
Centene
CNC
|
+$11.9M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 78.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Perrigo
PRGO
$3.06B
| $12.5M | 5.59% |
+75,000
| New | +$12.5M |
|
|
2
Smith & Nephew
SNN
$16.4B
| $12.5M | 5.56% |
+339,500
| New | +$12.5M |
|
|
RCPT
3
DELISTED
RECEPTOS INC COM STK (DE)
RCPT
| $12.3M | 5.46% |
+100,000
| New | +$12.3M |
|
|
4
Cooper Companies
COO
$13.3B
| $12.2M | 5.42% |
+300,000
| New | +$12.2M |
|
|
5
Centene
CNC
$16.3B
| $11.9M | 5.33% |
+460,000
| New | +$11.9M |
|
|
MDCO
6
DELISTED
Medicines Co
MDCO
| $11.1M | 4.94% |
+400,000
| New | +$11.1M |
|
7
Biogen
BIIB
$21.2B
| $11M | 4.92% |
+32,500
| New | +$11M |
|
8
Viatris
VTRS
$11.6B
| $11M | 4.9% |
+195,000
| New | +$11M |
|
9
Teva Pharmaceuticals
TEVA
$22.9B
| $10.4M | 4.62% |
+180,000
| New | +$10.4M |
|
|
SHPG
10
DELISTED
Shire pic
SHPG
| $10.1M | 4.5% |
+47,500
| New | +$10.1M |
|
|
MNK
11
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $9.9M | 4.42% |
+100,000
| New | +$9.9M |
|
12
Molina Healthcare
MOH
$9.8B
| $9.64M | 4.3% |
+180,000
| New | +$9.64M |
|
|
WMGI
13
DELISTED
Wright Medical Group Inc
WMGI
| $9.2M | 4.1% |
+342,500
| New | +$9.2M |
|
|
HNT
14
DELISTED
HEALTH NET INC
HNT
| $9.1M | 4.06% |
+170,000
| New | +$9.1M |
|
15
Humana
HUM
$33.2B
| $8.98M | 4% |
+62,500
| New | +$8.98M |
|
|
SIRO
16
DELISTED
SIRONA DENTAL SYSTEMS INC COM STK
SIRO
| $8.96M | 3.99% |
+102,500
| New | +$8.96M |
|
17
Zoetis
ZTS
$65.7B
| $8.82M | 3.93% |
+205,000
| New | +$8.82M |
|
|
CTRX
18
DELISTED
CATAMARAN CORP COM STK (CDA)
CTRX
| $8.28M | 3.69% |
+160,000
| New | +$8.28M |
|
19
Vertex Pharmaceuticals
VRTX
$101B
| $8.02M | 3.58% |
+67,500
| New | +$8.02M |
|
20
Edwards Lifesciences
EW
$45.5B
| $7.64M | 3.41% |
+360,000
| New | +$7.64M |
|
|
GEVA
21
DELISTED
SYNAGEVA BIOPHARMA CORP COM STK (DE)
GEVA
| $7.42M | 3.31% |
+80,000
| New | +$7.42M |
|
22
Intuitive Surgical
ISRG
$161B
| $6.88M | 3.07% |
+117,000
| New | +$6.88M |
|
23
Globus Medical
GMED
$7.93B
| $6.54M | 2.91% |
+275,000
| New | +$6.54M |
|